Back to announcement
20240731_INAF_Laporan Informasi dan Fakta Material_31689385.pdf
Financial statement Text extracted INAFSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 1246/DIR/VII/2024
Nama Perusahaan Indofarma Tbk.
Kode Emiten INAF
Lampiran 3
Penyampaian Laporan Keuangan
Perihal
Tahun Fiskal : 2024
Tahun Buku : MAR
Jenis Periode : Kuartal I / First Quarter
Dengan ini kami untuk dan atas nama perusahaan menyampaikan laporan keuangan, sebagai berikut:
Nama Emiten : Indofarma Tbk.
Bidang Usaha : Industri Farmasi dan Kesehatan
Nilai Ekuitas : (858.095.957.477)
Nilai Pendapatan Periode Sebelumnya : 169.795.451.850
Nilai Pendapatan : 43.637.479.215
Selisih dengan Nilai Pendapatan (126.157.972.635)
:
Periode Sebelumnya
Kurs : Rupiah / IDR
Rate : 1
Jenis Laporan atas Laporan Keuangan : Tidak Diaudit / Unaudit
Opini Audit : -
Demikian untuk diketahui.
Hormat Kami,
Indofarma Tbk.
Warjoko Sumedi
Corporate Secretary
Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Telepon : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Nama Pengirim Warjoko Sumedi
Jabatan Corporate Secretary
Page 2
Tanggal dan Waktu 31-07-2024 14:20
Lampiran 1. S-1246 Pengantar Laporan Keuangan TW1 2024.pdf
2. Surat Pernyataan Direksi.pdf
3. LK INAF Konsolidasi Maret 2024.pdf
Dokumen ini merupakan dokumen resmi Indofarma Tbk. yang tidak memerlukan tanda tangan karena dihasilkan
secara elektronik oleh sistem pelaporan elektronik. Indofarma Tbk. bertanggung jawab penuh atas informasi yang
tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 1246/DIR/VII/2024
Issuer Name Indofarma Tbk.
Issuer Code INAF
Attachment 3
Subject Submission of Financial Report
Fiscal Year : 2024
End of Year : MAR
Period Type : Kuartal I / First Quarter
The company hereby announce the Submission of Financial Report as follows:
Issuer Name : Indofarma Tbk.
Business Fields : Industri Farmasi dan Kesehatan
Equity Value : (858.095.957.477)
Previous Period Revenue : 169.795.451.850
Revenue : 43.637.479.215
Difference with Previous Period (126.157.972.635)
:
Revenue
Currency : Rupiah / IDR
Rate : 1
Types of Reports on Financial : Tidak Diaudit / Unaudit
Type of Auditor's Opinion : -
Thus to be informed accordingly.
Respectfully,
Indofarma Tbk.
Warjoko Sumedi
Corporate Secretary
Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Phone : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Sender Name Warjoko Sumedi
Function Corporate Secretary
Page 4
Date and Time 31-07-2024 14:20
Attachment 1. S-1246 Pengantar Laporan Keuangan TW1 2024.pdf
2. Surat Pernyataan Direksi.pdf
3. LK INAF Konsolidasi Maret 2024.pdf
This is an official document of Indofarma Tbk. that does not require a signature as it was generated electronically
by the electronic reporting system. Indofarma Tbk. is fully responsible for the information contained within this
document.
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.